A study was made of the effects of several monoamine-uptake inhibitors on membrane currents elicited by acetylcholine (ACh-currents) generated by rat neuronal ␣2␤4 and mouse muscle nicotinic acetylcholine receptors (AChRs) expressed in Xenopus laevis oocytes. For the two types of receptors the monoamine-uptake inhibitors reduced the ACh-currents albeit to different degrees. The order of inhibitory potency was norfluoxetine Ͼ clomipramine Ͼ indatraline Ͼ fluoxetine Ͼ imipramine Ͼ zimelidine Ͼ 6-nitro-quipazine Ͼ trazodone for neuronal ␣2␤4 AChRs, and norfluoxetine Ͼ fluoxetine Ͼ imipramine Ͼ clomipramine Ͼ indatraline Ͼ zimelidine Ͼ trazodone Ͼ 6-nitro-quipazine for muscle AChRs. Thus, the most potent inhibitor was norfluoxetine, whilst the weakest ones were trazodone, 6-nitro-quipazine and zimelidine. Effects of the tricyclic antidepressant imipramine were studied in more detail. Imipramine inhibited reversibly and non-competitively the ACh-current with a similar inhibiting potency for both neuronal ␣2␤4 and muscle AChRs. The half-inhibitory concentrations of imipramine were 3.65 ± 0.30 M for neuronal ␣2␤4 and 5.57 ± 0.19 M for muscle receptors. The corresponding Hill coefficients were 0.73 and 1.2 respectively. The inhibition of imipramine was slightly voltage-dependent, with electric distances of ෂ0.10 and ෂ0.12 for neuronal ␣2␤4 and muscle AChRs respectively. Moreover, imipramine accelerated the rate of decay of AChcurrents of both muscle and neuronal AChRs. The ACh-current inhibition was stronger when oocytes, expressing neuronal ␣2␤4 or muscle receptors, were preincubated with imipramine alone than when it was applied after the ACh-current had been generated, suggesting that imipramine acts also on non-activated or closed AChRs. We conclude that monoamine-uptake inhibitors reduce ACh-currents and that imipramine regulates reversibly and noncompetitively neuronal ␣2␤4 and muscle AChRs through similar mechanisms, perhaps by interacting externally on a non-conducting state of the AChR and by blocking the open receptor-channel complex close to the vestibule of the channel. These studies may be important for understanding the regulation of AChRs as well as for understanding antidepressant-and side-effects of monoamine-uptake inhibitors. Molecular Psychiatry (2001) 6, 511-519.
Introduction
Nicotinic acetylcholine receptors (AChRs) mediate the transmission of signals across the vertebrate neuromuscular junction as well as across central and peripheral synapses. 1 The AChR, a ligand-gated ion channel opened by acetylcholine, is a pentameric structure, composed of four different subunits in muscle receptors (␣1, ␤1, ␥, or ⑀, and ␦) with a stoichiometry of 2:1:1:1; whereas in neuronal ␣2␤4 AChRs the stoichiometry is presumably 2:3.
2, 3 The function of AChRs is modified by both endogenous and exogenous substances. 4, 5 Although serotonin (5-hydroxytryptamine, 5-HT) acts as neurotransmitter on specific receptors, 6 it has been shown that 5-HT is also able to modulate AChRs. Furthermore, various agonists and antagonists of different 5-HT receptors, as well as inhibitors of the 5-HTtransporter alter the function of neuronal and muscle AChRs. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] The most common action of serotonergic compounds on AChRs appears to be a non-competitive inhibitory process through interactions with the open channel. 5, [7] [8] [9] [10] [11] [12] [13] [14] On the other hand, it is known that different classes of inhibitors of monoamine-uptake systems, that are used clinically as antidepressants, interact with different membrane proteins at synaptic regions. For example: imipramine, trazodone, clomipramine, zimelidine, fluoxetine and norfluoxetine inhibit a wide variety of receptors including muscarine, histamine, adre-Molecular Psychiatry naline, dopamine and serotonin receptors, 18 and they also inhibit biogenic amine transporters. 19 In addition, fluoxetine, an antidepressant that initially was thought to be a very high selective inhibitor of the 5-HT uptake system, 20 inhibits nicotinic and serotonin receptors. 11, 13, 21, 22 Similarly, imipramine, a non-selective inhibitor of serotonin uptake, 23 blocks nicotinic receptors of frog motor endplate and electric organ in a noncompetitive and voltage-dependent way, 24 ,25 inhibits the current evoked by dimethylphenylpiperazinium in human neuroblastoma cells and blocks the secretion of ATP mediated by AChRs in chromaffin cells. 26, 27 In this paper, we studied effects of various inhibitors of monoamine transporters on neuronal ␣2␤4 and muscle AChRs, with emphasis on the mechanisms of action of imipramine.
Materials and methods
The experiments were performed on Xenopus oocytes expressing rat neuronal ␣2␤4 or embryonic mouse muscle AChRs. 9, 13 Briefly, oocytes were dissected from the ovary and maintained at 16°C in Barth's solution containing: 88 mM NaCl, 1 mM KCl, 0.33 mM Ca(NO 3 ) 2 , 0.41 mM CaCl 2 , 0.82 mM MgSO 4 , 2.4 mM NaHCO 3 , 5 mM HEPES (pH 7.4; NaOH), and 0.1 mg ml −1 gentamicin sulfate. The next day individual oocytes were injected with 0.5-5 ng of a mixture of cRNA subunits in a volume of 50 nl water (␣1, ␤1, ␥ and ␦ or ␣2 and ␤4). Two days later the oocytes were treated with 140 units ml −1 collagenase type I (Sigma, St Louis, MO, USA) for 0.5-1 h to remove the ovarian epithelial and follicular cells. 28 Membrane currents were recorded 3-9 days after RNA injection using a voltage-clamp technique with two microelectrodes 29 with a commercially available amplifier (Warner OC-725A; Warner Instruments Corp, Hamden, CT, USA), monitored with an oscilloscope (Nicolet 310; Nicolet Instruments Corp, Madison, WI, USA) and stored in discs for subsequent analyses using a program written by Rico Miledi. The oocytes were continuously superfused at room temperature (20-23°C) with frog Ringer's solution containing 115 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2 , 5 mM HEPES (pH 7.0; NaOH). Unless otherwise indicated, the oocyte membrane potential was maintained at −60 mV. Monoamine-uptake inhibitors were obtained from RBI (Natick, MA, USA). ACh and other drugs were diluted in Ringer and applied onto the oocytes by superfusion at a rate of 7-10 ml min −1 (chamber volume ෂ0.1 ml). Membrane current values are given as the mean ± standard error (SE).
The dose-response relationships for ACh-currents in the presence of imipramine were obtained by fitting the data with the Hill equation:
where I imip is the ACh-current amplitude in the presence of imipramine, I p is the control peak current, IC 50 is the half-inhibitory concentration of imipramine, and nH is the Hill coefficient. The dose-response relationships for ACh alone or for ACh plus imipramine were obtained by fitting the data with the Hill equation:
where I ACh is the ACh dose-dependent current amplitude in the absence or presence of imipramine, I max is the amplitude of the maximal ACh-current, EC 50 is the half-excitatory concentration of ACh, and nH is the Hill coefficient.
To determine if the imipramine-binding site on AChR is located externally or within the ion channel, a one-site blockage model was used. 10, 30 It assumes that the block caused by the drug is fast. The voltage dependence of the binding of the blocking agent is also related with the electrical distance of its binding site, measured from the external side of the membrane channel, and is given by the equation:
where IC 50 (0) is the half-blocking concentration at 0 mV, V m is the applied membrane potential, d is the fraction of the electrical field sensed at a binding site of imipramine within the receptor's ion channel, z is the valence of the blocking molecule, F is the Faraday constant, R is the gas constant, and T is the absolute temperature. Combining Equation (3) with the Hill equation for the blocking, Equation (1), gives: The time course of the decay of the ACh-current is influenced by several factors including the speed of the solution exchange, the size of the cell and the receptor desensitization 31 and can be fitted by the function:
where I(t) is the current at time t; I o is an asymptotic component; A f and A s are the amplitudes for a fast and a slow component; and f and s are their respective time constants.
Results

ACh-current decrease by monoamine-transporter inhibitors
Several monoamine-transporter inhibitors were tested on neuronal ␣2␤4 and muscle AChRs expressed in Xenopus oocytes. Control ACh-currents were elicited by low concentrations of ACh and after the peak had been reached, 10 M of a monoamine-transporter inhibitor was coapplied with ACh. After ෂ2 min the inhibitor was removed, to allow recovery of the AChcurrent ( Figure 1 ). The effect of each compound was estimated as the ratio between the current elicited by ACh plus the drug over the control ACh-current value at the end of the drug application, giving the fraction of the ACh-current that remains at this time ( Figure 1c ). These experiments disclosed two groups of com- pounds. The first group included the weakest ACh-current inhibitors: trazodone, 6-nitro-quipazine, and zimelidine (selective inhibitors of the 5-HT-transporter). The second group was constituted by the strongest ACh-current inhibitors: indatraline (an uptake inhibitor of 5-HT, dopamine and noradrenaline), clomipramine, imipramine (tricyclic antidepressants), fluoxetine (a highly selective inhibitor of the 5-HT-transporter) and norfluoxetine (a principal metabolite of fluoxetine).
After this brief screening, we focused on the effects of imipramine, that is used as antidepressant and is also considered as a reference drug in clinical studies. 32 
ACh-current inhibition by imipramine
When imipramine was applied alone (at concentrations up to 10 M) to injected or non-injected oocytes, no measurable membrane currents were observed. However, imipramine, at concentrations above 100 nM, inhibited rapidly and partially reversibly ACh-currents in oocytes expressing AChRs 
Non-competitive inhibition of AChRs by imipramine
We examined two forms of applying imipramine to oocytes expressing either neuronal ␣2␤4 or muscle AChRs. In one, the oocyte was superfused simultaneously with ACh and imipramine. In the other, the oocyte was preincubated with imipramine for 2 min and then the ACh and imipramine were coapplied. In both cases the concentration of imipramine was maintained constant and the ACh concentration was changed to obtain the full dose-response relationship ( Figure 3 ). With both procedures the level of AChcurrent inhibition was insurmountable by increasing ACh concentration and this inhibition was also independent of the concentration of ACh.
ACh dose-current response relationships were fitted with Equation 2. The half-effective concentrations, EC 50 , of ACh and the Hill coefficients, nH, were obtained when oocytes were superfused with ACh alone, simultaneously superfused with ACh plus imipramine and preincubated with imipramine (Table 1) . For both types of AChRs the EC 50 increased approximately twice in the presence of imipramine without The imipramine was applied simultaneously with or before ACh (ACh plus imip or imip preincubation respectively). Data were normalized to the maximal control AChcurrent and fitted by using Equation 2 (continuous lines). Insets: Representative superimposed records of the control AChcurrent and that obtained by simultaneous application of drugs. The number of oocytes recorded was n = 4-9 for neuronal ␣2␤4 and n = 5-10 for muscle AChRs (see Table 1 ).
changing the Hill coefficient, suggesting that the affinity of neuronal and muscle receptors for ACh is slightly reduced by imipramine, while maintaining normal cooperativity.
Additional forms of imipramine application
To explore if imipramine interacts with the close and/or activated states of the AChR, effects of various forms of imipramine application to oocytes expressing 
The values of EC 50 and nH were obtained from Equation 2.
The application of ACh and imipramine (imip) was simultaneous. n = number of oocytes studied.
either ␣2␤4 or muscle AChRs were tested (Figure 4) . Following two control applications of ACh the oocyte was preincubated briefly with imipramine and then exposed to ACh alone (a); the imipramine was applied after the ACh-current had reached its peak (b); the membrane current was elicited by simultaneous superfusion of ACh and imipramine (c); and the oocyte was preincubated with imipramine and then exposed immediately to ACh plus imipramine (d). It is interest- . The number of oocytes recorded was n = 5-7 for neuronal ␣2␤4 and n = 4 for muscle AChRs (see Table 2 ). 48.9 ± 4.8 (n = 5) 44.2 ± 4.5 (n = 4) ACh ACh + imip 56.9 ± 7.5 (n = 7) 51.1 ± 6.5 (n = 4) imip, ACh + imip 70.6 ± 3.8 (n = 6) 71.7 ± 1.7 (n = 4) a The membrane current was elicited by 0.5 M ACh and inhibited by 4 M imipramine for neuronal ␣2␤4 and 5 M imipramine for muscle AChRs. n = number of oocytes studied.
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ing to note that when imipramine was applied before ACh (Figure 4a) , the ACh-current inhibition was similar to that obtained when imipramine was applied after activation of the AChRs (cf Figure 4b, c) . In contrast, preincubation with imipramine, followed by coapplication with ACh resulted in the strongest inhibition of the ACh-current (Figure 4d ). These results (summarized in Table 2 ) suggest that imipramine interacts with both resting and activated AChRs.
Voltage-dependence of AChR inhibition by imipramine
To determine if imipramine is interacting within the ion channel or externally we studied the ACh-current inhibition as a function of membrane potential. oocyte expressing muscle AChRs. The membrane potential was held at −60 mV and voltage pulses to different levels (from −140 to 40 mV in 20-mV steps) were applied before and during ACh application, as well as in the presence of imipramine plus ACh. The results were analyzed using a simple one-site blocking model, 10, 30 that allows estimation of the 'electrical distance' (Equation 4). In oocytes expressing neuronal ␣2␤4 or muscle AChRs, the ACh-current in the presence of imipramine (I imipramine ) was compared with the control current (I ACh ) at each membrane potential (Figure 5b ). For both types of receptors the inhibition of ACh-current by imipramine was voltage-dependent, being stronger at hyperpolarized holding potentials. In the case of neuronal ␣2␤4 AChRs the calculated electrical distance was 0.10 ± 0.02 (n = 7), whereas for muscle AChRs it was 0.12 ± 0.02 (n = 6), indicating that imipramine interacts within the pore of the receptor-channel complex, close to its extracellular end. The halfinhibitory concentration of imipramine at a membrane potential of 0 mV, IC 50 (0), was 1.21 M for ␣2␤4 AChRs, whilst it was 3.61 M for muscle AChRs. In contrast, the values of IC 50 at −60 mV were similar for both types of receptors (Figure 2b ). Current-voltage (I-V) relationships for neuronal ␣2␤4 and muscle AChRs (Figure 5c, d) show an inward rectification that decreased slightly by imipramine.
Effects of imipramine on the decay of the AChcurrent
To explore the possibility that imipramine modifies the desensitization of AChRs, effects of imipramine on the decay of the ACh-currents were studied in oocytes expressing neuronal or muscle AChRs. The control membrane current was elicited by 100 M or 5 M ACh: for neuronal ␣2␤4 or muscle AChRs respectively. In both cases the control current reached a peak and then declined in the continuous presence of ACh, and the time-course of decay followed an exponential function. This decay is due to several factors such as the Figure 6 Imipramine accelerates the time course of the ACh-current. Records of the control current and that obtained in the presence of imipramine on neuronal ␣2␤4 (a) and muscle AChRs (b) are shown superimposed and normalized. Control current amplitudes were 4931 nA (a) and 54.6 A (b); whereas ACh-current amplitudes in the presence of imipramine were 1280 nA and 11.6 A respectively. The number of oocytes recorded was n = 4 for neuronal ␣2␤4 and n = 6 for muscle AChRs (see Table 3 ).
speed of the superfusion that determines the rate of solution exchange, the presence of unstirred layer close to the surface of the cell, the size and shape of the cell, desensitization of receptors. Considering that the first three of these factors are maintained constant during one experiment, we think that imipramine accelerates the decay of the ACh-current by blocking AChRs and accelerating the desensitization of receptors. For instance, when the ACh was simultaneously superfused with 7 M or 10 M imipramine (for neuronal ␣2␤4 or muscle AChRs), the peak current was substantially reduced and the rate of decay was accelerated ( Figure 6 ). The averaged peak control current was 2.86 A for neuronal ␣2␤4 and 34.27 A for muscle AChRs; whereas the averaged peak ACh-current in the presence of imipramine was 0.76 A for neuronal ␣2␤4 and 8.97 A for muscle AChRs.
We compared the rate of ACh-current decay in the absence and presence of imipramine in two ways. Firstly, we defined D ft as the fraction of the AChcurrent that was reduced after 5 min of the application of ACh alone or ACh plus imipramine, compared with its own peak current. This value was lower for control ACh-currents than for ACh-currents in the presence of imipramine, indicating less degree of decay in control ACh-currents and probably less desensitization (Table 3) . Secondly, the current decay was fitted with Table 3 Amplitudes and time constants of the components of the ACh-current decay of neuronal and muscle AChRs In contrast, in the presence of imipramine the AChcurrent decayed biphasically, following the sum of two exponential functions and a steady-state component; where the two time constants of the decay were faster than the time constant of the corresponding control ACh-current (Table 3) . These results suggest that imipramine might accelerate the desensitization of AChRs. Additionally, with high ACh concentrations, a transient tail current was elicited when ACh and imipramine were simultaneously washed out. This effect was more evident for muscle than for neuronal ␣2␤4 AChRs ( Figure 6 ). However, when ACh was removed leaving the imipramine in the superfusing fluid, the transient inward current was not observed. This suggests a reversal of the open channel blockage by imipramine, similar to that seen with atropine and ACh itself.
9,33
Discussion
The present study shows that several substances, used widely as antidepressants, have an inhibitory effect on the ACh-current generated by the activation of AChRs expressed in Xenopus oocytes. Our results show that the imipramine exerts a non-competitive inhibition on muscle AChRs. This result is in agreement with previous reports carried out on AChRs of the electric organ of Torpedo and frog muscle. 24, 25 However, the location of the binding site of imipramine on these receptors is not clear. It has been proposed that the imipramine binding site is the same as that for phencyclidine and perhydrohistrionicotoxin, which is located within the channel, 24 in contrast with other studies suggesting that the binding site of imipramine, also located within the channel, is different. 25 On the other hand, the electrical distance for spiperone on muscle AChRs was d = 0.17, 10 similar to the value obtained here for imipramine (d = 0.12), suggesting that both drugs interact at the same or closely related site of the muscle AChR.
In contrast to effects of imipramine that had no effect on current rise or decay times in frog motor endplate, 25 we observed that imipramine accelerates in a concentration-dependent manner the rate of decay of AChcurrents generated by both neuronal and muscle AChRs. For instance, when the concentration of imipramine was increased the ACh-current decay, and probably its desensitization, became faster. The different results may be due to molecular differences in the M2 region between frog and mouse muscle AChRs, 34 similar to the difference in affinity to phencyclidine between AChRs from Torpedo electric organ and mouse muscle; which is based on a difference in three amino acids within the ionic channel. 35 It has been reported that ACh potentials in rat soleus muscle fibers are potentiated with 1 M imipramine. 25 However, under our experimental conditions even smaller concentrations of imipramine exerted an inhibitory effect on the ACh-current. Further studies are necessary to clarify these differences, which may be due to the different types of receptors and cells examined.
The non-competitive inhibition of both neuronal and muscle AChRs by imipramine shows that the drug exerts its effects by a steric mechanism with a similar affinity. Considering the electric distance (ෂ0.10) for both types of receptors, it seems likely that the binding site of imipramine is within the ionic channel, close to its extracellular end, similar to the binding site of many non-competitive inhibitors, including chlorpromazine and histrionicotoxin. 5 In addition, it appears that in both neuronal and muscle AChRs, imipramine binds to the resting receptor and prevents it from the opening of the ionic channel.
Nearly three decades ago it was reported that serotonin inhibits the AChRs of the neuromuscular junction. 36 This effect was subsequently widely confirmed for both muscle and neuronal AChRs. 7, [9] [10] [11] 37 Such a cross-interaction between serotonin and AChRs needs to be considered in explaining the varied effects of antidepressant drugs, bearing in mind that two inhibitory effects may occur on AChRs, one exerted by the antidepressant and the another by the non-competitive inhibitory effect of serotonin.
Few papers have studied effects of imipramine on muscle 24, 25 and neuronal 26, 27 AChRs. Here we complemented previous studies and performed a comparative electrophysiological characterization of effects of imipramine on muscle and neuronal AChRs. A new finding was that imipramine acts on both types of AChRs through similar mechanisms, probably interacting within the ionic channel at the same site and accelerating the desensitization of AChRs. Also this is the first study in which effects of substances such as norfluoxetine, indatraline, zimelidine, 6-nitro-quipazine and trazodone have been explored on nicotinic receptors. It has become increasingly important to determine the effects of antidepressants on neurotransmitter receptors and ionic channels, because the role played by them on mental depression and other diseases is not completely understood. For instance, fluoxetine has an inhibitory effect on muscle as well as on neuronal AChRs, 11, 13, 16, 17, 22 histamine H 1 , adrenergic ␣ 1 and ␣ 2 and muscarinic receptors, 19 and voltage-activated K + and Na + channels. 38 Finally, it is possible that the actions of imipramine, inhibiting neuronal AChRs, are related with therapeutic-and/or side-effects, because the concentration of imipramine in blood of depressed patients may reach ෂ2 M, 39 and that the concentration in the brain is 11-16 fold higher, 40 compared with the IC 50 for imipramine (3.65 M) on neuronal ␣2␤4 AChRs studied here. Additionally, the demethylated metabolite of imipramine, desipramine, that is more concentrated in blood and brain than imipramine, 40 exerts a similar activity in the neuroblastoma cell line SH-SY5Y. 26 These cells express AChR ␣3, ␣5, ␣7, ␤2, and ␤4 subunit genes. 41 Thus, it is very likely that imipramine interacts with AChRs in the peripheral and central nervous systems. Further studies are required to clarify how AChRs are involved in a number of physiological and behavioral processes 42 and how these drugs exert their action on other AChR subtypes.
